Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Parkinson`s Disease |
📓
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons. International journal of molecular sciences (Int J Mol Sci ) Vol: 22 Issue 16 Pages: Pub: 2021 Aug 13 Epub: 2021 Aug 13 Authors Sini P , Dang TBC , Fais M , Galioto M , Padedda BM , Lugliè A , Iaccarino C , Crosio C , Html Article Publication |
| Parkinson`s Disease |
📓
Desulfovibrio Bacteria Are Associated With Parkinson`s Disease. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 652617 Pub: 2021 Epub: 2021 May 3 Authors Murros KE , Huynh VA , Takala TM , Saris PEJ , Html Article Publication |
| Parkinson`s Disease |
📓
Association of Parkinson`s Disease With Microbes and Microbiological Therapy. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 619354 Pub: 2021 Epub: 2021 Mar 8 Authors Chen ZJ , Liang CY , Yang LQ , Ren SM , Xia YM , Cui L , Li XF , Gao BL , Html Article Publication |
| Parkinson`s Disease |
📓
Meta-analysis of the Parkinson`s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinson`s disease (NPJ Parkinsons Dis ) Vol: 7 Issue 1 Pages: 27 Pub: 2021 Mar 10 Epub: 2021 Mar 10 Authors Romano S , Savva GM , Bedarf JR , Charles IG , Hildebrand F , Narbad A , Html Article Publication |
| Parkinson`s Disease |
📓
Meta-analysis of the Parkinson`s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinson`s disease (NPJ Parkinsons Dis ) Vol: 7 Issue 1 Pages: 27 Pub: 2021 Mar 10 Epub: 2021 Mar 10 Authors Romano S , Savva GM , Bedarf JR , Charles IG , Hildebrand F , Narbad A , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
